XML 95 R78.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidating Financial Information (Statements of Cash Flows) (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities $ 27,896 $ (4,936)
Cash flows from investing activities:    
Sale of investment securities 13,456 51,218
Maturities of investment securities 7,174 343
Purchase of investment securities (14,974) (29,112)
Purchase of long-term investments (22,400) 0
Investments in real estate ventures (1,436) (5,795)
Distributions from investments in real estate ventures 0 12
Increase in cash surrender value of life insurance policies (49) (62)
Decrease (increase) in restricted assets 1,156 (3,017)
Payments to Acquire Notes Receivable (1,500) 0
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 2 0
Capital expenditures (4,588) (3,915)
Pay downs of investment securities 864 2,174
Investments in real estate, net (70) (49)
Net cash (used in) provided by investing activities (22,365) 11,797
Cash flows from financing activities:    
Proceeds from issuance of debt 850,000 57
Deferred financing costs (19,200) 0
Repayments of debt (835,697) (1,576)
Borrowings under revolver 39,956 59,426
Repayments on revolver (68,305) (41,482)
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (52,358) (48,876)
Contributions from non-controlling interest 0 248
Distributions to non-controlling interest 0 (5,978)
Proceeds from issuance of Vector stock 43,230 0
Net cash used in financing activities (42,374) (38,181)
Net decrease in cash and cash equivalents (36,843) (31,320)
Cash and cash equivalents, beginning of period 393,530 240,368
Cash and cash equivalents, end of period 356,687 209,048
Consolidating Adjustments [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (47,657) (50,157)
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Purchase of long-term investments 0  
Investments in real estate ventures 0 0
Distributions from investments in real estate ventures   0
Increase in cash surrender value of life insurance policies 0 0
Decrease (increase) in restricted assets 0 0
Payments to Acquire Notes Receivable 0  
Investments in subsidiaries 535 471
Proceeds from sale of fixed assets 0  
Capital expenditures 0 0
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities 535 471
Cash flows from financing activities:    
Proceeds from issuance of debt 0 0
Deferred financing costs 0  
Repayments of debt 0 0
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received (535) (471)
Intercompany dividends paid 47,657 50,157
Dividends and distributions on common stock 0 0
Contributions from non-controlling interest   0
Distributions to non-controlling interest   0
Proceeds from issuance of Vector stock 0  
Net cash used in financing activities 47,122 49,686
Net decrease in cash and cash equivalents 0 0
Cash and cash equivalents, beginning of period 0 0
Cash and cash equivalents, end of period 0 0
Parent/Issuer [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities (28,282) 12,633
Cash flows from investing activities:    
Sale of investment securities 13,456 46,497
Maturities of investment securities 7,174 343
Purchase of investment securities (14,974) (29,112)
Purchase of long-term investments (22,400)  
Investments in real estate ventures 0 0
Distributions from investments in real estate ventures   0
Increase in cash surrender value of life insurance policies 0 0
Decrease (increase) in restricted assets (3) (3)
Payments to Acquire Notes Receivable 0  
Investments in subsidiaries (535) (471)
Proceeds from sale of fixed assets 0  
Capital expenditures (6) (18)
Pay downs of investment securities 864 2,174
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities (16,424) 19,410
Cash flows from financing activities:    
Proceeds from issuance of debt 850,000 0
Deferred financing costs (19,200)  
Repayments of debt (835,000) 0
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 0 0
Intercompany dividends paid 0 0
Dividends and distributions on common stock (52,358) (48,876)
Contributions from non-controlling interest   0
Distributions to non-controlling interest   0
Proceeds from issuance of Vector stock 43,230  
Net cash used in financing activities (13,328) (48,876)
Net decrease in cash and cash equivalents (58,034) (16,833)
Cash and cash equivalents, beginning of period 279,815 111,470
Cash and cash equivalents, end of period 221,781 94,637
Subsidiary Guarantors [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 95,873 30,671
Cash flows from investing activities:    
Sale of investment securities 0 4,721
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Purchase of long-term investments 0  
Investments in real estate ventures 0 0
Distributions from investments in real estate ventures   0
Increase in cash surrender value of life insurance policies (49) (62)
Decrease (increase) in restricted assets 1,159 (3,014)
Payments to Acquire Notes Receivable 0  
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 2  
Capital expenditures (1,096) (2,618)
Pay downs of investment securities 0 0
Investments in real estate, net 0 0
Net cash (used in) provided by investing activities 16 (973)
Cash flows from financing activities:    
Proceeds from issuance of debt 0 0
Deferred financing costs 0  
Repayments of debt (654) (1,545)
Borrowings under revolver 39,956 59,426
Repayments on revolver (68,305) (41,482)
Capital contributions received 100 100
Intercompany dividends paid (45,646) (34,908)
Dividends and distributions on common stock 0 0
Contributions from non-controlling interest   0
Distributions to non-controlling interest   0
Proceeds from issuance of Vector stock 0  
Net cash used in financing activities (74,549) (18,409)
Net decrease in cash and cash equivalents 21,340 11,289
Cash and cash equivalents, beginning of period 14,798 12,375
Cash and cash equivalents, end of period 36,138 23,664
Subsidiary Non-Guarantors [Member]    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 7,962 1,917
Cash flows from investing activities:    
Sale of investment securities 0 0
Maturities of investment securities 0 0
Purchase of investment securities 0 0
Purchase of long-term investments 0  
Investments in real estate ventures (1,436) (5,795)
Distributions from investments in real estate ventures   12
Increase in cash surrender value of life insurance policies 0 0
Decrease (increase) in restricted assets 0 0
Payments to Acquire Notes Receivable (1,500)  
Investments in subsidiaries 0 0
Proceeds from sale of fixed assets 0  
Capital expenditures (3,486) (1,279)
Pay downs of investment securities 0 0
Investments in real estate, net (70) (49)
Net cash (used in) provided by investing activities (6,492) (7,111)
Cash flows from financing activities:    
Proceeds from issuance of debt 0 57
Deferred financing costs 0  
Repayments of debt (43) (31)
Borrowings under revolver 0 0
Repayments on revolver 0 0
Capital contributions received 435 371
Intercompany dividends paid (2,011) (15,249)
Dividends and distributions on common stock 0 0
Contributions from non-controlling interest   248
Distributions to non-controlling interest   (5,978)
Proceeds from issuance of Vector stock 0  
Net cash used in financing activities (1,619) (20,582)
Net decrease in cash and cash equivalents (149) (25,776)
Cash and cash equivalents, beginning of period 98,917 116,523
Cash and cash equivalents, end of period $ 98,768 $ 90,747